Pharmacy Times: CBD Products 'Are Simply Not Regulated, That's the Problem'

Without clear potency testing guidelines and label regulations from Congress or the FDA, CBD companies could be more likely to mislabel or provide lower quality products to consumers. 

Sunsoil's CEO discusses the need for product transparency within the CBD industry and the resulting benefit to consumers. 

Read the full article from Pharmacy Times